More good news for advocates legalized marijuana use in the United States as new studies have suggested more evidence the benefits cannabis. While we’ve seen links between improved conditions for those suffering ailments such as glaucoma and some cancers and cannabis use, new research also points to the plant as a ble solution to the ongoing opioid epidemic in the United States.
In new data released by the Minnesota Department Health, numbers indicate that 63 percent patients surveyed in a study were able to reduce or eliminate opioid usage after six months being registered with the states medical cannabis program. But this is hardly the first time that such findings have been presented. Back in 2016, the state Michigan reported similar findings, revealing that a 64 percent decrease in opioid usage was closely associated with marijuana treatment.
Overseas, more definitive research has supported this as well as such research is easier to conduct in nations where the substance is legalized. A recent study published in the European Journal Internal Medicine showed that researchers from Israel’s largest medical marijuana provider found that cannabis could help “stop opioid dependency before it starts.”
“Cannabis is a very good alternative to reduce opioid consumption, to increase quality life, and to reduce pain, nausea and vomiting,” Lihi Bar-Lev Schleider, lead researcher on the study, told Rolling Stone magazine. Similar to other findings, a time frame six months was all it took to reduce patients’ use and abuse opioid painkillers.